![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CELLULAR AND MOLECULAR
7-Nicotinic Acetylcholine Receptors Heterologously Expressed in the SH-EP1 Human Epithelial Cell Line
Divisions of Neurology, Barrow Neurological Institute, Phoenix, Arizona (L.Z., J.W.) and Neurobiology (Y.-P.K., A.A.G., J.-H.P., M.S.P., K.M.S., R.J.L.), Barrow Neurological Institute, Phoenix, Arizona
7-Nicotinic acetylcholine receptors (
7-nAChRs) are broadly
distributed in the central nervous system, where they play important roles in
chemical and electrical signaling, and perhaps in neurite outgrowth, synaptic
plasticity, and neuronal death/survival. To help elucidate their normal and
pathophysiological roles, we have heterologously expressed human
7-nAChR in transfected SH-EP1 human epithelial cells. Reverse
transcription-polymerase chain reaction and mRNA fluorescence in situ
hybridization analyses demonstrate expression of human
7 subunits as
messenger RNA. Patch-clamp recordings exploiting a novel strategy to prevent
functional rundown of whole-cell peak current responses to repeated acute
challenges with nicotinic agonists show successful expression of functional
7-nAChR that mediate inward currents characterized by rapid phases of
activation and inactivation. Concentration-response curves show that nicotine,
acetylcholine, and choline are efficacious agonists at human
7-nAChRs.
Current-voltage relationships show inward rectification for agonist-induced
currents. Human
7-nAChRs exhibit some sensitivity to
7-nAChR
antagonists
-bungarotoxin (Bgt) or methyllycaconitine (MLA) when
applied coincidentally with agonist, but much higher affinity block occurs
when cells and
7-nAChRs are pre-exposed to antagonists for 2 min before
challenge with agonist. Both Bgt and MLA are competitive inhibitors of
7-nAChR function. Whole-cell current peak amplitudes and half-times for
inactivation of
7-nAChR functional responses to nicotine are
dramatically reduced in the absence of extracellular
Ca2+, suggestive of high Ca2+
permeability of the
7-nAChR channel. Thus, heterologously expressed
human
7-nAChR in mammalian cells have properties of native
7-nAChR or of
7-nAChR heterologously expressed in other systems
and serve as excellent models for studies of molecular bases of
7-nAChR
function.
Address Correspondence to: Dr. Jie Wu, Division of Neurology, Barrow Neurological Institute, 350 West Thomas Rd., Phoenix, AZ 85013-4496. E-mail: jwu2{at}chw.edu
This article has been cited by other articles:
![]() |
K. Yang, J. Hu, L. Lucero, Q. Liu, C. Zheng, X. Zhen, G. Jin, R. J. Lukas, and J. Wu Distinctive nicotinic acetylcholine receptor functional phenotypes of rat ventral tegmental area dopaminergic neurons J. Physiol., January 15, 2009; 587(2): 345 - 361. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. G. Farias, A. S. Valles, M. Colombres, J. A. Godoy, E. M. Toledo, R. J. Lukas, F. J. Barrantes, and N. C. Inestrosa Wnt-7a Induces Presynaptic Colocalization of {alpha}7-Nicotinic Acetylcholine Receptors and Adenomatous Polyposis Coli in Hippocampal Neurons J. Neurosci., May 16, 2007; 27(20): 5313 - 5325. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wu, Q. Liu, K. Yu, J. Hu, Y.-P. Kuo, M. Segerberg, P. A. St John, and R. J. Lukas Roles of nicotinic acetylcholine receptor {beta} subunits in function of human {alpha}4-containing nicotinic receptors J. Physiol., October 1, 2006; 576(1): 103 - 118. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hu, K. Lindenberger, G. Hu, H. Wang, R. J. Lukas, and J. Wu Iptakalim as a Human Nicotinic Acetylcholine Receptor Antagonist J. Pharmacol. Exp. Ther., February 1, 2006; 316(2): 914 - 925. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. T. Hawkins, R. D. Egleton, and T. P. Davis Modulation of cerebral microvascular permeability by endothelial nicotinic acetylcholine receptors Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H212 - H219. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Akk, L. S Milescu, and M. Heckmann Activation of heteroliganded mouse muscle nicotinic receptors J. Physiol., April 15, 2005; 564(2): 359 - 376. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. Peng, J. D. Fryer, R. S. Hurst, K. M. Schroeder, A. A. George, S. Morrissy, V. E. Groppi, S. S. Leonard, and R. J. Lukas High-Affinity Epibatidine Binding of Functional, Human {alpha}7-Nicotinic Acetylcholine Receptors Stably and Heterologously Expressed de Novo in Human SH-EP1 Cells J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 24 - 35. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Williams, B. Burton, A. Urrutia, A. Shcherbatko, L. E. Chavez-Noriega, C. J. Cohen, and J. Aiyar Ric-3 Promotes Functional Expression of the Nicotinic Acetylcholine Receptor {alpha}7 Subunit in Mammalian Cells J. Biol. Chem., January 14, 2005; 280(2): 1257 - 1263. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Sacco, K. L. Bannon, and T. P. George Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders J Psychopharmacol, December 1, 2004; 18(4): 457 - 474. [Abstract] [PDF] |
||||
![]() |
J. Wu, A. A. George, K. M. Schroeder, L. Xu, S. Marxer-Miller, L. Lucero, and R. J. Lukas Electrophysiological, Pharmacological, and Molecular Evidence for {alpha}7-Nicotinic Acetylcholine Receptors in Rat Midbrain Dopamine Neurons J. Pharmacol. Exp. Ther., October 1, 2004; 311(1): 80 - 91. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wu, Y.-P. Kuo, A. A. George, L. Xu, J. Hu, and R. J. Lukas {beta}-Amyloid Directly Inhibits Human {alpha}4{beta}2-Nicotinic Acetylcholine Receptors Heterologously Expressed in Human SH-EP1 Cells J. Biol. Chem., September 3, 2004; 279(36): 37842 - 37851. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Lang, R. Burgstahler, W. Sippel, D. Irnich, B. Schlotter-Weigel, and P. Grafe Characterization of Neuronal Nicotinic Acetylcholine Receptors in the Membrane of Unmyelinated Human C-Fiber Axons by In Vitro Studies J Neurophysiol, November 1, 2003; 90(5): 3295 - 3303. [Abstract] [Full Text] [PDF] |
||||